36. Epidermolysis bullosa Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 163 / Drugs : 185 - (DrugBank : 46) / Drug target genes : 50 - Drug target pathways : 125
| Other names | - | ||
|---|---|---|---|
| Disease group | Skin and connective tissue diseases | ||
|
Domestic patients
Med expenses recipients (FY2023) |
289 patients Age distribution
 💬 |
||
| Related info (in Japanese) | |||
| Clinical research form [April 1, 2025 ~] (in Japanese) | Overview, diagnostic criteria, etc. (pdf), Clinical research form (pdf) | ||
| Specific pediatric chronic diseases, Japan (in Japanese) | 14-3-8. epidermolysis bullosa | ||
| Subtypes | No. | Name | Specific pediatric chronic diseases, Japan (in Japanese) |
| 36-1. | Epidermolysis bullosa simplex;EBS; | 14-3-8. epidermolysis bullosa | |
| 36-2. | Junctional epidermolysis bullosa;JEB;Junctional epidermolysis bullosa type Herlitz;JEB-H;Junctional epidermolysis bullosa type non-Herlitz;JEB-nH; | 14-3-8. epidermolysis bullosa | |
| 36-3. | Dominant dystrophic epidermolysis bullosa;DDEB;Dystrophic epidermolysis bullosa;DEB;Epidermolysis bullosa dystrophica; | 14-3-8. epidermolysis bullosa | |
| 36-4. | Recessive dystrophic epidermolysis bullosa;RDEB;Dystrophic epidermolysis bullosa;DEB;Epidermolysis bullosa dystrophica; | 14-3-8. epidermolysis bullosa | |
| 36-5. | Kindler syndrome; | 14-3-8. epidermolysis bullosa | |